Karuna Therapeutics Sees Breakthrough In Schizophrenia Drug
Karuna Therapeutics' top-experimental schizophrenia drug significantly reduced symptoms in a late-stage trial but there were concerns that it could cause hypertension in patients.
Since 2010, at least 100,000 people bitten by a lone star tick have become allergic to mammal meat, milk and other mammal-derived products such as gelatin.